What is TROGARZO® | TROGARZO®

A BREAKTHROUGH IN HIV-1 TREATMENT

TROGARZO® is a medicine that’s used in combination with other antiretroviral medicines to treat HIV-1 infection in adults who:

HAVE BEEN ON DIFFERENT HIV-1 TREATMENT REGIMENS IN THE PAST

HAVE HIV-1 THAT IS RESISTANT TO ANTIRETROVIRAL MEDICINES

ARE CURRENTLY ON AN HIV-1 TREATMENT REGIMEN THAT IS FAILING

THE FIRST LONG-ACTING ANTIVIRAL AGAINST HIV-1.

Is TROGARZO® Right For You?

LONG-ACTING TROGARZO® WORKS DIFFERENTLY

TROGARZO® is a biologic, an antibody created specifically to protect your T-cells from the virus.
Most antiretroviral medicines aim to prevent HIV-1 from multiplying inside the immune system’s T-cells.
TROGARZO® binds to the T-cell’s surface to block HIV-1 from entering. This can help protect the T-cell and reduce your viral load.

Is TROGARZO® Right For You?

CLINICALLY PROVEN
EFFICACY AND SAFETY

In a clinical study, TROGARZO® was proven to have a significant and long-lasting impact on the amount of HIV-1 in the body, reducing your viral load. In addition, studies showed that Patients who reached undetectable levels were able to remain undetectable over time. Most (90%) of the adverse reactions reported with TROGARZO® were mild or moderate in severity. The most common adverse reactions reported were diarrhea, dizziness, nausea, and rash. TROGARZO® does not interact with other drugs, so you can take it with other medications you may be taking. Be sure to discuss other medications you may need with your healthcare provider before taking TROGARZO®.

How Do You Take TROGARZO®?

Start The Conversation

Download the Discussion Guide to help you start the conversation with your healthcare provider about TROGARZO®. Ensure you are getting the most from your HIV-1 treatment by asking the right questions.

Download Discussion Guide

IMPORTANT SAFETY INFORMATION

Do not receive TROGARZO® if you have had an allergic reaction to TROGARZO® or any of the ingredients in TROGARZO®.

TROGARZO® can cause serious side effects, including:

Allergic reactions. TROGARZO® can cause allergic reactions, including serious reactions, during and after infusion. Tell your healthcare provider or nurse, or get medical help right away if you get any of the following symptoms of an allergic reaction:
- trouble breathing
- swelling in your throat
- wheezing
- chest pain
- chest tightness
- cough
- hot flush
- nausea
- vomiting
Changes in your immune system (Immune Reconstitution Inflammatory Syndrome) can happen when you start taking HIV-1 medicines. Your immune system might get stronger and begin to fight infections that have been hidden in your body for a long time. Tell your health care provider right away if you start having new symptoms after receiving TROGARZO®.

The most common side effects of TROGARZO® include diarrhea, dizziness, nausea, and rash. These are not all the possible side effects of TROGARZO®.

Before you receive TROGARZO®, tell your healthcare provider about all of your medical conditions, including if you are:

Pregnant or plan to become pregnant. It is not known if TROGARZO® may harm your unborn baby. Tell your healthcare provider if you become pregnant during treatment with TROGARZO®.
Breastfeeding or plan to breastfeed. You should not breastfeed if you have HIV-1 because of the risk of passing HIV-1 to your baby. Do not breastfeed if you are receiving TROGARZO® as it is not known if TROGARZO® passes into breast milk. Talk with your healthcare provider about the best way to feed your baby during treatment with TROGARZO®.

Also, tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

For more information or medical advice about side effects, ask your healthcare provider. You may report side effects to the FDA at 1-800-FDA-1088 or the THERA patient support® at 1-833-23THERA (1-833-238-4372).

WHAT IS TROGARZO®?

TROGARZO® (ibalizumab-uiyk) is a prescription medicine that is used with other antiretroviral medicines to treat Human Immunodeficiency Virus-1 (HIV-1) infection in adults who:

have received anti-HIV-1 regimens in the past, and
have HIV-1 virus that is resistant to antiretroviral medicines, and
who are failing their current antiretroviral therapy

It is not known if TROGARZO® is safe and effective in children.

Please see full Prescribing Information for TROGARZO®.

References:

Theratechnologies Inc. TROGARZO® Prescribing Information. April 2021.
Department of Health and Human Services. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV. 2021. Available at: https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/AdultandAdolescentGL.pdf. Retrieved September 10, 2021.

A BREAKTHROUGH IN HIV-1 TREATMENT

LONG-ACTING TROGARZO® WORKS DIFFERENTLY

LONG-ACTING TROGARZO® WORKS DIFFERENTLY

CLINICALLY PROVENEFFICACY AND SAFETY

Start The Conversation

IMPORTANT SAFETY INFORMATION

WHAT IS TROGARZO®?

CLINICALLY PROVEN
EFFICACY AND SAFETY